Tilray

(NASDAQ: TLRY)
Healthcare  |  Drug Manufacturers—Specialty & Generic
7.46 -0.3 -3.87%
Stock Price | Aug. 7, 2020, 4 p.m.
6 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 7.76
52 Week Low: 2.43
52 Week High: 46.2499
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 08/07/20

3 Comments
Yesterday
2 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 08/05/20

1 Comments
3 days ago

Premium Weekly Review 07/24/20

1 Comments
2 weeks ago

Premium Weekly Review 07/17/20

3 weeks ago

Premium Cannabis Stocks Review - AM Edition 07/07/20

5 Comments
1 month ago

Premium Assessing Focus List Prospects Over the Balance of 2020

4 Comments
1 month ago

Premium Cannabis Stocks Review - Weekend Edition 07/06/20

4 Comments
1 month ago

Premium Cannabis Stocks Review - Pre-Market Edition 07/01/20

6 Comments
1 month ago
1 month ago